OBJECTIVE： To provide reference for improving the utilization rate of medical resources， the compliance of patients with chemotherapy and the rational use of drugs. METHODS： The working model of day-time chemtherapy center and the model of full-course pharmaceutical care were introduced in our hospital. The effects of full-course pharmaceutical care were summarized. RESULTS： As one of the core team members of the multidisciplinary collaborative working group on day-time chemotherapy， clinical pharmacists participated in the selection of chemotherapy schemes， the formulation of clinical pathways， the formulation of inclusion criteria for patients undergoing day-time chemotherapy， and the participation in information management of day-time chemotherapy centers. With the intervention of clinical pharmacists， prescription pharmacists and dispensing pharmacists， the patients were provided with full-course pharmaceutical care relying on pharmacy intravenous admixture service （PIVAS）， including the combination of pre-reviewing and real-time reviewing to examine and verify the medical orders for chemotherapeutic drugs， standardizing deployment of PIVAS chemotherapeutic drugs， real-time monitoring of the whole process of drug use in the background with the help of closed-loop management information system， actively providing pharmaceutical care， medication education and so on. The full-course pharmaceutical care model could effectively reduce irrational drug use. The qualified rates of chemotherapy pretreatment， hydration rate， administration sequence， flushing tube， placement time， drip rate for chemotherapy injection increased from 76％， 50％， 94％， 50％， 54％， 54％ before providing full-course pharmaceutical course （May-Jul. 2017） to 100％， 100％， 100％， 100％， 94％ and 96％ after providing full-course pharmaceutical course （Sept.-Nov. 2017）. CONCLUSIONS： The development of full-course pharmaceutical care in day-time chemotherapy center can improve the utilization of medical resources， patient compliance and rational drug use.